Owing to the results, such as ANKRD22 remarkably expressed in the tumor group, potentially contributing to the NF-kB pathway and metastatic process, the qPCR and western blot could be conducted to investigate relevant components. This evidence concerns the gene ANKRD22 and neoplasm.